Filtros de búsqueda

Lista de obras de Christine Katlama

476 Reasons for the lack of anti-HBc antibody detection in hepatitis B virus infected patients

article by V. Avettand-Fenoel et al published April 2006 in Journal of Hepatology

A Step Ahead on the HIV Collaboratory

artículo científico publicado en 2009

A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndrome

artículo científico publicado en 2008

A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study ⬇️

artículo científico publicado el 31 de agosto de 2010

A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects

artículo científico publicado en 1998

A lectin-binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity ⬇️

artículo científico publicado el 1 de marzo de 1991

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients.

artículo científico publicado en 2009

A randomized trial to evaluate continuation versus discontinuation of lamivudine in individuals failing a lamivudine-containing regimen: the COLATE trial.

artículo científico publicado en 2006

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

artículo científico publicado en 2003

A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection

artículo científico publicado en 2013

AIDS across Europe, 1994-98: the EuroSIDA study

artículo científico publicado en 2000

AIDS-related malignancies: state of the art and therapeutic challenges

artículo científico publicado en 2008

APOL1 variants may induce HIV-associated nephropathy during HIV primary infection

artículo científico publicado en 2017

Abacavir (Ziagen(®)) use between 2003 and 2008 in France according to the electronic medical record NADIS(®).

artículo científico publicado en 2013

Acquired immunodeficiency syndrome (AIDS) in Africans.

artículo científico publicado en 1984

Activity of the integrase inhibitor S/GSK1349572 in subjects with HIV exhibiting raltegravir resistance: week 24 results of the VIKING study (ING112961).

artículo científico publicado en 2010

Acute generalized exanthematous pustulosis induced by HIV postexposure prophylaxis with lopinavir-ritonavir

artículo científico publicado en 2005

Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy

artículo científico publicado en 1998

Adjustment of antiretroviral regimen may lead to HBV reactivation even in patients with past HBV infection serological profile ⬇️

artículo científico publicado el 5 de febrero de 2013

Ageing with HIV: do comorbidities and polymedication drive treatment optimization?

artículo científico publicado en 2016

An in vivo pharmacokinetic/pharmacodynamic model for antiretroviral combination

artículo científico publicado en 2003

Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients

artículo científico publicado en 2006

Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection

artículo científico publicado en 2013

Antiretroviral combinations implicated in emergence of the L74I and L74V resistance mutations in HIV-1-infected patients

artículo científico publicado en 2009

Antiretroviral therapy and immune reconstitution

artículo científico publicado en 1999

Antiretroviral therapy with a twice-daily regimen containing 400 milligrams of indinavir and 100 milligrams of ritonavir in human immunodeficiency virus type 1-infected women during pregnancy

artículo científico publicado en 2008

Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response

artículo científico publicado en 2014

Antiretroviral-induced toxiderma in HIV-infected patients

artículo científico publicado el 6 de septiembre de 2003

Are specific antiretrovirals associated with an increased risk of discontinuation due to toxicities or patient/physician choice in patients with hepatitis C virus coinfection?

artículo científico publicado en 2005

Association of Gag cleavage sites to protease mutations and to virological response in HIV-1 treated patients

artículo científico publicado en 2006

Astrocytic adhesion molecules are increased in HIV-1-associated cognitive/motor complex

artículo científico publicado en 1997

Atazanavir in patients with persistent viral replication despite HAART: results from the French prospective NADIS cohort

artículo científico publicado en 2008

Atazanavir/ritonavir-based combination antiretroviral therapy for treatment of HIV-1 infection in adults

artículo científico publicado en 2011

Atypical ocular manifestation of primary varicella zoster virus infection as the first manifestation of AIDS.

artículo científico publicado en 2016

Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery

artículo científico publicado en 2003

Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs

artículo científico publicado en 2013

Bivariate Longitudinal Model For The Analysis Of The Evolution Of Hiv Rna And Cd4 Cell Count In Hiv Infection Taking Into Account Left Censoring Of Hiv Rna Measures

article

Blackwater fever after ingestion of mefloquine. Three cases

artículo científico publicado en 1993

Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

artículo científico publicado en 2019

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

artículo científico publicado en 2015

Breast cancer among HIV infected individuals from the ONCOVIH study, in France: Therapeutic implications

artículo científico publicado en 2012

CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection

artículo científico publicado en 1992

CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle

artículo científico publicado en 2000

CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope

artículo científico publicado en 2011

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel

artículo científico publicado en 2002

Cellular CD4 T cell responses to the diphtheria-derived carrier protein of conjugated pneumococcal vaccine and antibody response to pneumococcal vaccination in HIV-infected adults

artículo científico publicado en 2010

Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment

artículo científico publicado en 1987

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

artículo científico publicado en 2001

Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia

artículo científico publicado en 2013

Changing electrolyte and acido-basic profile in HIV-infected patients in the HAART era

article

Changing incidence of central nervous system diseases in the EuroSIDA cohort

artículo científico

Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting

artículo científico publicado en 2012

Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.

artículo científico publicado en 2004

Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin

artículo científico publicado en 2017

Classic and extracavitary primary effusion lymphoma in 51 HIV-infected patients from a single institution

artículo científico publicado en 2016

Clinical features and risk factors for atazanavir (ATV)-associated urolithiasis: a case-control study

artículo científico publicado en 2014

Clinical trials for heavily pretreated patients: update in 2006.

artículo científico publicado en 2006

Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

artículo científico publicado en 2004

Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution

artículo científico publicado en 2005

Codevelopment of new antiretrovirals in very treatment-experienced HIV-infected individuals

artículo científico publicado en 2004

Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).

artículo científico publicado en 2014

Combination of two pathways involved in raltegravir resistance confers dolutegravir resistance

artículo científico publicado en 2015

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach

artículo científico publicado en 2015

Comparative effectiveness of continuing a virologically effective first-line boosted protease inhibitor combination or of switching to a three-drug regimen containing either efavirenz, nevirapine or abacavir

artículo científico publicado en 2011

Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

artículo científico publicado en 2014

Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load

artículo científico publicado en 2015

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

artículo científico publicado en 2004

Comparison of the dynamics of resistance-associated mutations to nucleoside reverse transcriptase inhibitors, nonnucleoside reverse transcriptase inhibitors, and protease inhibitors after cessation of antiretroviral combination therapy.

artículo científico publicado en 2004

Comparison of two genotypic algorithms to determine HIV-1 tropism

artículo científico publicado en 2008

Comparison of two genotypic algorithms to determine HIV-1 tropism*

article

Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV-Infected Individuals

artículo científico publicado en 2016

Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccine

artículo científico publicado en 2011

Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection

artículo científico publicado en 2002

Current clinical aspects of HIV/AIDS

artículo científico publicado en 2002

Cutaneous vasculitis disclosing pulmonary tuberculosis

artículo científico publicado en 2000

Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy

artículo científico publicado en 1999

Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia

artículo científico publicado en 2017

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

artículo científico publicado en 2003

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection

artículo científico publicado en 2004

Determinants of a Low CD4/CD8 Ratio in HIV-1-Infected Individuals Despite Long-term Viral Suppression

artículo científico publicado en 2016

Development and validation of a specific method for relative HBV-genotype G (G-HBV) quantification in the context of co-infection with other genotypes ⬇️

artículo científico publicado el 6 de septiembre de 2010

Dialysis and Renal Transplantation in HIV-Infected Patients: a European Survey ⬇️

artículo científico publicado el 15 de diciembre de 2010

Dideoxyinosine-associated hypokalaemia ⬇️

artículo científico publicado el 19 de enero de 1991

Differential impact of APOBEC3-driven mutagenesis on HIV evolution in diverse anatomical compartments

artículo científico publicado en 2014

Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients

artículo científico publicado en 2013

Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy

artículo científico publicado en 2001

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

article

Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations

artículo científico publicado en 2017

Disseminated infection with a mycobacterium related to Mycobacterium triplex with central nervous system involvement associated with AIDS

artículo científico publicado en 2003

Distribution, characteristics, and prognostic of AIDS and non-AIDS cancers in HIV-infected patients, the ONCOVIH study

artículo científico publicado en 2009

Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?

artículo científico publicado en 2018

Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia

artículo científico publicado en 2016

Dolutegravir for the treatment of HIV.

artículo científico

Down-regulation of CD8+ T-cell expansions in patients with human immunodeficiency virus infection receiving highly active combination therapy

artículo científico publicado en 2001

Drug interactions between antineoplastic and antiretroviral therapies: Implications and management for clinical practice

artículo científico publicado en 2008

Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1.

artículo científico publicado en 2013

Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials

artículo científico publicado en 2005

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r

artículo científico publicado en 2006

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups

artículo científico publicado en 2000

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

artículo científico publicado en 2012

E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations

artículo científico publicado en 2011

Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals

artículo científico publicado en 2006

Early detection of hepatitis C virus infection using a new combined antigen-antibody detection assay: potential use in HIV co-infected individuals

artículo científico publicado en 2006

Early virologic failure and rescue therapy of tenofovir, abacavir, and lamivudine for initial treatment of HIV-1 infection: TONUS study

artículo científico publicado en 2005

Early virological failure in naive human immunodeficiency virus patients receiving saquinavir (soft gel capsule)-stavudine-zalcitabine (MIKADO trial) is not associated with mutations conferring viral resistance

artículo científico publicado en 2000

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

artículo científico publicado en 1996

Efficacy and Tolerability of Stavudine plus Lamivudine in Treatment-Naive and Treatment-Experienced Patients with HIV-1 Infection

artículo científico publicado el 1 de octubre de 1998

Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2007

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

artículo científico publicado en 2008

Efficacy and safety of an antiretroviral regimen containing etravirine plus raltegravir in HIV-1 treatment-experienced patients failing darunavir

article

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

artículo científico publicado en 2007

Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus

artículo científico publicado en 1997

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials

artículo científico publicado en 2010

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials

artículo científico publicado en 2009

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial.

artículo científico publicado en 2015

Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.

artículo científico publicado en 2009

Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals.

artículo científico publicado en 2003

Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study

article

Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial

artículo científico publicado en 2018

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort

artículo científico publicado en 2014

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients

artículo científico publicado en 2003

Efficacy of darunavir/ritonavir maintenance monotherapy in patients with HIV-1 viral suppression: a randomized open-label, noninferiority trial, MONOI-ANRS 136.

artículo científico publicado en 2010

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients

artículo científico publicado en 2006

Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia

artículo científico publicado en 2003

Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients

artículo científico publicado en 1995

Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study

artículo científico publicado en 2010

Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score

artículo científico publicado en 2013

Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection

artículo científico publicado en 2009

Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide

artículo científico

Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994

artículo científico publicado en 1998

Epidemiological features and incidence trends of primary cerebral lymphomas observed in 80 HIV-infected patients from 1983 to 1999 ⬇️

artículo científico publicado el 1 de septiembre de 2001

Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.

artículo científico publicado en 1996

Epidemiology of cryptosporidiosis among European AIDS patients

artículo científico publicado en 1996

Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.

artículo científico publicado en 2012

Etravirine Concentrations in the Cervicovaginal Compartment in HIV-1-Infected Women Receiving Etravirine-Containing Antiretroviral Therapy: DIVA 02 Study ⬇️

artículo científico publicado el 23 de abril de 2012

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV.

artículo científico publicado en 2008

Evaluating therapeutic vaccines in patients infected with HIV.

artículo científico publicado en 2004

Evaluation of compliance with antiretroviral treatment in a cohort of 200 patients in Djibouti, 2005

artículo científico publicado en 2007

Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study

artículo científico publicado en 1995

Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men.

artículo científico

Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.

artículo científico publicado en 2008

Extracerebral toxoplasmosis in patients infected with HIV. A French National Survey.

artículo científico publicado en 1994

Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy

article

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

artículo científico publicado en 2001

Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients

article

Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy

artículo científico publicado en 2013

Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study

artículo científico publicado en 2003

Factors associated with proviral DNA HIV-1 tropism in antiretroviral therapy-treated patients with fully suppressed plasma HIV viral load: implications for the clinical use of CCR5 antagonists

artículo científico publicado en 2010

Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir

artículo científico publicado en 2007

Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients

artículo científico publicado en 2016

Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir

artículo científico publicado en 2005

First-line cART regimen impacts the course of CD8+ T-cell counts in HIV-infected patients that achieve sustained undetectable viral load

scientific article published on October 2016

Foscarnet and crystals in glomerular capillary lumens

artículo científico publicado en 1990

Foscarnet salvage therapy for patients with late-stage HIV disease and multiple drug resistance

artículo científico publicado en 2006

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial

artículo científico publicado en 2017

Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B.

artículo científico publicado en 2013

Frequency of hepatic steatosis in HIV and hepatitis C co-infected patients treated by antiretroviral therapy during 1995 to 2008

article

Fungal infection as a risk factor for HIV disease progression among patients with a CD4 count above 200/microl in the era of cART.

artículo científico publicado en 2008

GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy

artículo científico publicado en 2004

Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients

artículo científico publicado en 2010

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

artículo científico publicado en 2014

Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes

artículo científico publicado en 2009

Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali

artículo científico publicado en 2007

Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patients

artículo científico publicado en 2003

Genotypic resistance analysis of the virological response to fosamprenavir-ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials

artículo científico publicado en 2008

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

article

Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452)

article

HIV

artículo científico publicado en 2018

HIV and cancer : What's new in 2017?

artículo científico publicado en 2018

HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis

artículo científico publicado en 2011

HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen

artículo científico publicado en 2007

HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis

article

HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.

artículo científico publicado en 2019

HIV-1 X4/R5 co-receptor in viral reservoir during suppressive HAART

article

HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirs

artículo científico publicado en 2012

HIV-1 or hepatitis C chronic infection in serodiscordant infertile couples has no impact on infertility treatment outcome

artículo científico publicado en 2009

HIV-1 reverse transcriptase (RT) genotype and susceptibility to RT inhibitors during abacavir monotherapy and combination therapy

artículo científico publicado en 2000

HIV-1 specific antibody titers and neutralization among chronically infected patients on long-term suppressive antiretroviral therapy (ART): a cross-sectional study

artículo científico publicado en 2014

HIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects

artículo científico publicado en 2016

HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex

artículo científico publicado en 1993

HIV-related non-Hodgkin's lymphoma among European AIDS patients. AIDS in Europe Study Group. AIDS in Europe Study Group

article

Health-related quality of life after 1 year of highly active antiretroviral therapy

artículo científico publicado en 2003

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals

article

Hepatic steatosis in HIV-HCV coinfected patients receiving antiretroviral therapy is associated with HCV-related factors but not antiretrovirals.

artículo científico publicado en 2013

Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus

artículo científico publicado en 1999

Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals

artículo científico publicado en 2017

High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors

artículo científico publicado en 2003

High prevalence of antiretroviral drug resistance among HIV-1-untreated patients in Guinea-Conakry and in Niger

artículo científico publicado en 2011

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance

artículo científico publicado en 2014

High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO trial

artículo científico publicado en 2009

High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy

artículo científico publicado en 2005

Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response

artículo científico publicado en 2015

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

artículo científico publicado en 2013

Historical HIV-RNA resistance test results are more informative than proviral DNA genotyping in cases of suppressed or residual viraemia

artículo científico

Human CMV infection of the CNS: concordance between PCR detection in CSF and pathological examination

artículo científico publicado en 1993

Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine

artículo científico publicado en 2002

Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome

artículo científico publicado en 1997

IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia

artículo científico publicado en 2003

INSTI-Based Triple Regimens in Treatment-Naïve HIV-Infected Patients Are Associated With HIV-RNA Viral Load Suppression at Ultralow Levels

article

Immune and virological benefits of 10 years of permanent viral control with antiretroviral therapy

artículo científico publicado en 2010

Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection

artículo científico publicado en 2006

Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells

artículo científico publicado en 2000

Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score

artículo científico publicado en 2011

Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes

artículo científico publicado en 2009

Impact of gag mutations on selection of darunavir resistance mutations in HIV-1 protease

artículo científico publicado en 2008

Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: the HEPADOSE study

artículo científico publicado en 2010

Impact of lean mass and bone density on glomerular filtration rate estimation in people living with HIV/AIDS.

artículo científico publicado en 2017

Impact of stavudine phenotype and thymidine analogues mutations on viral response to stavudine plus lamivudine in ALTIS 2 ANRS trial

artículo científico publicado en 2002

Improved detection of resistance at failure to a tenofovir, emtricitabine and efavirenz regimen by ultradeep sequencing

artículo científico publicado en 2015

In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.

artículo científico publicado en 2004

Incidence and risk factors of thrombocytopenia in patients receiving intermittent antiretroviral therapy: a substudy of the ANRS 106-window trial

artículo científico publicado en 2009

Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).

artículo científico publicado en 2003

Individualized antiretroviral therapeutic approaches: less can be more

artículo científico publicado en 2017

Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients

artículo científico publicado en 2000

Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies

artículo científico publicado en 2017

Influence of antigen exposure on the loss of long-term memory to childhood vaccines in HIV-infected patients

artículo científico publicado en 2009

Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis

artículo científico publicado en 2011

Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial

artículo científico publicado en 2008

Intensification of stable background therapy with abacavir in antiretroviral therapy experienced patients: 48‐week data from a randomized, double‐blind trial ⬇️

artículo científico publicado el 1 de enero de 2001

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial

artículo científico publicado en 2015

Interleukin 2 treatment does not modify hepatitis B or C replication in human immunodeficiency virus-infected patients: results from a randomized control trial

artículo científico publicado en 2002

Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.

artículo científico publicado en 2002

Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death

artículo científico publicado en 2007

Interruption of nonnucleoside reverse transcriptase inhibitor (NNRTI) therapy for 2 months has no effect on levels of human immunodeficiency virus type 1 in plasma of patients harboring viruses with mutations associated with resistance to NNRTIs

artículo científico publicado en 2003

Is long-term virological response related to CCR5 Delta32 deletion in HIV-1-infected patients started on highly active antiretroviral therapy?

artículo científico publicado en 2009

Isolation of a new human retrovirus from West African patients with AIDS.

artículo científico publicado en 1986

LAV type II: a second retrovirus associated with AIDS in West Africa

artículo científico publicado en 1986

LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation

artículo científico publicado en 2015

Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country

artículo científico publicado en 2015

Legionellosis in HIV-1 infected patients. 4 case reports

artículo científico publicado en 2002

Les nouvelles molécules anti-VIH : la place du raltégravir

Line Probe Assay for Detection of Human Immunodeficiency Virus Type 1 Mutations Conferring Resistance to Nucleoside Inhibitors of Reverse Transcriptase: Comparison with Sequence Analysis ⬇️

artículo científico publicado el 1 de julio de 1998

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

artículo científico publicado en 2009

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

artículo científico publicado en 1999

Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease ⬇️

artículo científico publicado el 6 de junio de 1998

Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

artículo científico publicado en 2010

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients

artículo científico publicado en 2016

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study.

artículo científico publicado en 2010

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study ⬇️

artículo científico publicado el 7 de diciembre de 2011

Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection

artículo científico publicado en 2014

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

artículo científico publicado en 1999

Longitudinal and integrative biomodeling of effector and memory immune compartments after inactivated influenza vaccination

artículo científico publicado en 2013

Low frequency of HIV-1 tropism evolution in patients successfully treated for at least 2 years

article

Low frequency of intermittent HIV-1 semen excretion in patients treated with darunavir-ritonavir at 600/100 milligrams twice a day plus two nucleoside reverse transcriptase inhibitors or monotherapy

artículo científico publicado en 2010

Low lipolytic enzyme activity in patients with severe hypertriglyceridemia on highly active antiretroviral therapy

artículo científico publicado en 2001

Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice

artículo científico publicado en 2015

Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.

artículo científico publicado en 2001

Lung cancer in patients with HIV Infection and review of the literature

artículo científico publicado en 2004

Lymph-node tuberculosis in patients infected or not with HIV: general characteristics, clinical presentation, microbiological diagnosis and treatment ⬇️

artículo científico publicado el 1 de octubre de 2003

Lymphadenopathy-associated virus type 2 in AIDS and AIDS-related complex. Clinical and virological features in four patients

artículo científico publicado en 1987

Lymphopenia-driven homeostatic regulation of naive T cells in elderly and thymectomized young adults

artículo científico publicado en 2012

M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine

artículo científico publicado en 2002

MIKADO: a multicentre, open‐label pilot study to evaluate the antiretroviral activity and safety of saquinavir with stavudine and zalcitabine ⬇️

artículo científico publicado el 1 de enero de 2001

MIV-310 reduces HIV viral load in patients failing multiple antiretroviral therapy: results from a 4-week phase II study

artículo científico publicado en 2004

Management of therapeutic failure in HIV-infected patients

artículo científico publicado en 2001

Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients

artículo científico publicado en 2010

Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study

artículo científico publicado en 2014

Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms

artículo científico publicado en 2010

Maraviroc: clinical trials results

artículo científico publicado en 2008

Markov modelling of changes in HIV-specific cytotoxic T-lymphocyte responses with time in untreated HIV-1 infected patients

artículo científico publicado en 2003

Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription

article

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.

artículo científico publicado en 2005

Muscle and liver lactate metabolism in HAART-treated and naive HIV-infected patients: the MITOVIR study

artículo científico publicado en 2005

Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro

artículo científico publicado en 2008

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

artículo científico publicado en 2009

Médecine et Maladies Infectieuses. Editorial

artículo científico publicado en 2009

NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapy

artículo científico publicado en 2013

Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism

artículo científico publicado en 2012

Nephrotoxicity of ritonavir

artículo científico publicado en 1998

Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1

artículo científico publicado en 2004

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile

artículo científico publicado en 2001

New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies

artículo científico publicado en 2020

New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors

artículo científico publicado en 2014

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients

artículo científico publicado en 2005

Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group

artículo científico publicado en 2015

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

artículo científico

Novel antiretroviral combinations in treatment-experienced patients with HIV infection: rationale and results

artículo científico publicado en 2010

Nucleoside reverse transcriptase inhibitor-sparing regimen (nonnucleoside reverse transcriptase inhibitor + protease inhibitor) was more likely associated with resistance comparing to nonnucleoside reverse transcriptase inhibitor or protease inhibit

artículo científico publicado en 2009

O.116 Reasons for the lack of anti-HBC antibody detection in hepatitis B virus chronically infected patients

article by V. Avettand-Fenoel et al published January 2006 in Journal of Clinical Virology

Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients

artículo científico publicado en 2011

P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitors

artículo científico publicado en 2003

POWER 1 and 2: combined final 144-week efficacy and safety results for darunavir/ritonavir (DRV/r) 600/100 mg BID in treatment-experienced HIV patients

article

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

artículo científico publicado en 2010

Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance

artículo científico publicado en 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

artículo científico publicado en 2004

Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

artículo científico publicado en 2004

Pentamidine and pancreatitis

artículo científico publicado en 1986

Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype

artículo científico publicado en 2016

Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission

artículo científico

Pharmacokinetics of etravirine, raltegravir and darunavir/ritonavir in treatment experienced patients ⬇️

artículo científico publicado el 23 de octubre de 2010

Pharmacokinetics of foscarnet after twice-daily administrations for treatment of cytomegalovirus disease in AIDS patients ⬇️

artículo científico publicado el 1 de septiembre de 1992

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients

artículo científico publicado en 2010

Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combination antiretroviral therapy in highly treatment-experienced patients (BI Study 118

artículo científico publicado en 2008

Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study: Figure 1

artículo científico publicado en 2015

Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy

artículo científico publicado en 2000

Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA.

artículo científico publicado en 2003

Polymorphism of the human immunodeficiency virus type 1 (HIV-1) protease gene and response of HIV-1-infected patients to a protease inhibitor

artículo científico publicado en 1999

Positive impact of HIV-1 gag cleavage site mutations on the virological response to darunavir boosted with ritonavir

artículo científico publicado en 2011

Potential efficacy of fumagillin in intestinal microsporidiosis due to Enterocytozoon bieneusi in patients with HIV infection: results of a drug screening study. The French Microsporidiosis Study Group

artículo científico publicado en 1997

Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial

artículo científico publicado en 2010

Preferred antiretroviral drugs for the next decade of scale up.

artículo científico publicado en 2012

Prescribing and using self-injectable antiretrovirals: how concordant are physician and patient perspectives?

artículo científico publicado en 2009

Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma

artículo científico publicado en 2009

Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice

artículo científico publicado en 2001

Primary genotypic resistance of HIV-1 to CCR5 antagonists in CCR5 antagonist treatment-naive patients

artículo científico publicado en 2008

Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients

artículo científico publicado en 2007

Primary infection with a lamivudine-resistant hepatitis B virus ⬇️

artículo científico publicado el 4 de enero de 2002

Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelines

artículo científico publicado en 2010

Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study

artículo científico publicado en 2005

Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study

artículo científico publicado en 1998

Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

artículo científico publicado en 1996

Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy

article

Quantitative analysis of human mitochondrial DNA using a real-time PCR assay

artículo científico publicado en 2003

Quantitative markers for cytomegalovirus disease in HIV-infected patients receiving highly active antiretroviral therapy

artículo científico publicado en 2003

Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients

artículo científico publicado en 2009

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

artículo científico publicado en 2017

Raltegravir as functional monotherapy leads to virological failure and drug resistance in highly treatment-experienced HIV-infected patients

artículo científico publicado en 2010

Raltegravir concentrations in the genital tract of HIV-1-infected women treated with a raltegravir-containing regimen (DIVA 01 study)

artículo científico publicado en 2011

Raltegravir has no residual antiviral activity in vivo against HIV-1 with resistance-associated mutations to this drug

artículo científico publicado en 2009

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

artículo científico publicado en 2011

Raltegravir with optimized background therapy for resistant HIV-1 infection

artículo científico publicado en 2008

Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients ⬇️

artículo científico publicado el 7 de agosto de 2011

Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study

artículo científico publicado en 2014

Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

artículo científico publicado en 2009

Re-occurrence of HIV-1 drug mutations after treatment re-initiation following interruption in patients with multiple treatment failure ⬇️

artículo científico publicado el 9 de noviembre de 2001

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

article

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

article

Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial

artículo científico publicado en 2008

Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy.

artículo científico publicado en 1997

Regional differences in the risk of triple class failure in European patients starting combination antiretroviral therapy after 1 January 1999

Regional differences in use of antiretroviral agents and primary prophylaxis in 3122 European HIV-infected patients. EuroSIDA Study Group

artículo científico publicado en 1997

Relapses of CMV retinitis after 2 years of highly active antiretroviral therapy

artículo científico publicado en 2000

Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia

artículo científico publicado en 2006

Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy

artículo científico publicado en 2006

Renal insufficiency induced by ritonavir in HIV-infected patients.

artículo científico publicado en 1998

Renal tolerance of combined treatment with foscarnet and indinavir ⬇️

artículo científico publicado el 1 de marzo de 1998

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

artículo científico publicado en 2005

Report of chloroquine resistance malaria in Niger

artículo científico publicado en 1991

Residual immune activation in combined antiretroviral therapy-treated patients with maximally suppressed viremia

artículo científico publicado en 2015

Resistance analyses in highly experienced patients failing raltegravir, etravirine and darunavir/ritonavir regimen ⬇️

artículo científico publicado el 13 de noviembre de 2010

Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients

artículo científico publicado en 2005

Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen

artículo científico publicado en 2001

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patients

artículo científico publicado en 2004

Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens

artículo científico publicado en 2012

Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes

artículo científico publicado en 2009

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy

artículo científico publicado en 2012

Retinal and extraocular cytomegalovirus end-organ disease in HIV-infected patients in Europe: a EuroSIDA study, 1994-2001.

artículo científico

Risk Factors of Chronic Kidney Disease in HIV-infected Patients

article

Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patients

artículo científico publicado en 2006

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

artículo científico publicado en 2005

Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).

artículo científico publicado en 2018

Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial

artículo científico publicado en 2018

Ritonavir-Boosted Tipranavir Demonstrates Superior Efficacy to Ritonavir-Boosted Protease Inhibitors in Treatment-Experienced HIV-Infected Patients: 24-Week Results of the RESIST-2 Trial

article

Role of HIV-1 minority populations on resistance mutational pattern evolution and susceptibility to protease inhibitors

artículo científico publicado en 2006

Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).

artículo científico publicado en 2013

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

artículo científico publicado en 2013

Sacral zona complicated by acute bladder retention. One other indication of acyclovir

artículo científico publicado en 1990

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

artículo científico publicado en 2001

Safety and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced patients: 24-week results of POWER 3.

artículo científico publicado en 2007

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study

artículo científico publicado en 2012

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

artículo científico publicado en 2000

Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group

artículo científico publicado en 1996

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

artículo científico publicado en 2007

Safety and tolerability of etravirine (ETR; TMC125) in hepatitis B and/or C co-infected patients in DUET-1 and DUET-2: pooled 48-week results

scholarly article by B Clotet et al published 2008 in Journal of the International AIDS Society

Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks

artículo científico publicado en 2005

Safety of etravirine in HIV-1/hepatitis B and/or C virus co-infected patients: pooled 96 week results from the Phase III DUET trials ⬇️

artículo científico publicado el 27 de agosto de 2010

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

artículo científico publicado en 2003

Severe acute disseminated toxoplasmosis acquired by an immunocompetent patient in French Guiana

artículo científico publicado en 2002

Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis

artículo científico publicado en 2017

Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy ⬇️

artículo científico publicado el 1 de noviembre de 2012

Silent Cerebral Small-Vessel Disease Twice as Prevalent in Middle-Aged Well-Controlled cART-Treated HIV-Infected Individuals Than HIV-Uninfected Individuals

artículo científico publicado en 2017

Similar evolution of cellular HIV-1 DNA level in darunavir/ritonavir monotherapy versus triple therapy in MONOI-ANRS136 trial over 96 weeks

artículo científico publicado en 2012

Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy

artículo científico publicado en 2015

Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors

artículo científico publicado en 2010

Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

artículo científico publicado en 2008

Stability of HIV RNA in plasma specimens stored at different temperatures

artículo científico publicado en 2008

Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection

artículo científico publicado en 2008

Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group

artículo científico publicado en 1998

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group

artículo científico publicado en 1997

Survival of European patients with Kaposi's sarcoma as AIDS-defining condition during the first decade of AIDS. AIDS in Europe Study Group

artículo científico publicado en 1997

Susceptibility of HIV-1 isolates to zidovudine: correlation between widely applicable culture test and PCR analysis

artículo científico publicado el 1 de enero de 1992

Switch from enfuvirtide to raltegravir in virologically suppressed multidrug-resistant HIV-1-infected patients: a randomized open-label trial

artículo científico publicado en 2009

Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study

artículo científico publicado en 2012

Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremia

artículo científico publicado en 2015

Switch to second-line ART in West African routine care: incidence and reasons for switching

artículo científico publicado en 2011

Switching the nucleoside reverse transcriptase inhibitor backbone to tenofovir disoproxil fumarate + emtricitabine promptly improves triglycerides and low-density lipoprotein cholesterol in dyslipidaemic patients

artículo científico

Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.

artículo científico publicado en 2012

Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment

artículo científico publicado en 2007

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection

artículo científico publicado en 1989

TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals

artículo científico

TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results

artículo científico publicado en 2003

Tackling latency as a barrier to an HIV cure: what next?

artículo científico publicado en 2015

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment ⬇️

artículo científico publicado el 28 de enero de 2012

The HIV-1 antisense protein (ASP) induces CD8 T cell responses during chronic infection

artículo científico publicado en 2015

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

artículo científico publicado en 2006

The Level of Human Immunodeficiency Virus (HIV) Type 1 RNA in Cerebrospinal Fluid As a Marker of HIV Encephalitis ⬇️

artículo científico publicado el 1 de mayo de 1998

The Nadis cohort: 6236 HIV-infected patients followed up in French university hospitals

artículo científico publicado en 2005

The marriage of science and optimized HIV care in resource-limited settings

artículo científico publicado en 2008

The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study Team

artículo científico publicado en 2000

The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years

artículo científico publicado en 2007

The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study

artículo científico publicado en 2011

The tyrosine kinase inhibitor Dasatinib blocks in-vitro HIV-1 production by primary CD4+ T cells from HIV-1 infected patients

artículo científico publicado en 2014

Therapeutic immunization in HIV infection

artículo científico publicado en 2006

Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094).

artículo científico publicado en 2005

Therapeutic vaccines against HIV need international partnerships

artículo científico publicado en 2003

Thrombocytopenia is associated with an increased risk of cancer during treated HIV disease

artículo científico publicado en 2014

Thymidine analogue reverse transcriptase inhibitors resistance mutations profiles and association to other nucleoside reverse transcriptase inhibitors resistance mutations observed in the context of virological failure

artículo científico publicado en 2004

Tipranavir in highly ARV-experienced patients: efficacy and tolerability results from the French prospective NADIS cohort

article

Tolosa-Hunt syndrome revealing Burkitt lymphoma in an HIV-seropositive patient

artículo científico publicado el 6 de septiembre de 2003

Towards an HIV cure: a global scientific strategy

artículo científico publicado en 2012

Towards eradication of human immunodeficiency virus (HIV)?

artículo científico publicado en 2013

Toxic reaction following treatment of typhoid fever with pefloxacin

artículo científico publicado en 1990

Toxoplasma gondii pneumonia in patients with the acquired immunodeficiency syndrome

artículo científico publicado en 1990

Toxoplasmosis reactivation following HAART introduction associated with foetal death in a severely immune suppressed HIV-infected woman: an immune reconstitution inflammatory syndrome (IRIS) consequence?

article

Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans

artículo científico publicado en 2008

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

artículo científico publicado en 2001

Transmitted Drug Resistant HIV-1 and Association With Virologic and CD4 Cell Count Response to Combination Antiretroviral Therapy in the EuroSIDA Study

artículo científico publicado en 2008

Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali

artículo científico publicado en 2012

Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial

artículo científico publicado en 2016

Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment

artículo científico publicado en 2001

Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

artículo científico publicado en 2016

Treatment of AIDS-Associated Gastrointestinal Cytomegalovirus Infection with Foscarnet and Ganciclovir: A Randomized Comparison ⬇️

artículo científico publicado el 1 de septiembre de 1995

Treatment of acute HCV infection in HIV-positive patients: experience from a multicentre European cohort

artículo científico publicado en 2010

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy

artículo científico publicado en 1988

Treatment of the acquired immune deficiency syndrome—related Kaposi's sarcoma with bleomycin as a single agent ⬇️

artículo científico publicado el 1 de noviembre de 1990

Tuberculosis among European patients with the acquired immune deficiency syndrome. The AIDS in Europe Study Group

artículo científico publicado en 1996

Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study

artículo científico publicado en 2012

Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation

artículo científico publicado en 2017

Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies

artículo científico publicado en 2018

Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations

artículo científico publicado en 2011

Usefulness of Kaposi sarcoma-associated herpesvirus (KSHV)-DNA viral load in whole blood for the diagnosis and monitoring of KSHV-associated diseases

artículo científico publicado en 2018

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

artículo científico

Vaccine therapy in early HIV-1 infection using a recombinant canarypox virus expressing gp160MN (ALVAC-HIV): a double-blind controlled randomized study of safety and immunogenicity.

artículo científico publicado en 1997

Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure

artículo científico publicado en 2014

Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study

artículo científico publicado en 2008

Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma level

artículo científico publicado en 2004

Virological and pharmacological factors associated with virological response to salvage therapy after an 8-week of treatment interruption in a context of very advanced HIV disease (GigHAART ANRS 097).

artículo científico publicado en 2005

Virological diagnosis of progressive multifocal leukoencephalopathy: detection of JC virus DNA in cerebrospinal fluid and brain tissue of AIDS patients.

artículo científico publicado en 1993

Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).

artículo científico publicado en 2015

Virological failure among patients on HAART from across Europe: results from the EuroSIDA study

artículo científico publicado en 2000

Virological markers in the cerebrospinal fluid from HIV-1-infected individuals

artículo científico publicado en 1991

Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

scholarly article by T Bommenel et al published 2010 in Journal of the International AIDS Society

Virological rebound after suppression on highly active antiretroviral therapy

artículo científico publicado en 2003

Warning: antiretroviral treatment interruption could lead to an increased risk of HIV transmission

artículo científico publicado en 2002

Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study

article

Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials

artículo científico publicado en 2006

[CCR5 antagonists: a new class of antiretrovirals].

artículo científico publicado en 2009

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda